Lister J - Search Results

1

Treatment of acute myelogenous leukemia with outpatient azacitidine.

Sudan N, Rossetti JM, Shadduck RK, Latsko J, Lech JA, Kaplan RB, Kennedy M, Gryn JF, Faroun Y, Lister J. Sudan N, et al. Among authors: lister j. Cancer. 2006 Oct 15;107(8):1839-43. doi: 10.1002/cncr.22204. Cancer. 2006. PMID: 16967444 Free article.

2

Activity of azacitidine in chronic myelomonocytic leukemia.

Costa R, Abdulhaq H, Haq B, Shadduck RK, Latsko J, Zenati M, Atem FD, Rossetti JM, Sahovic EA, Lister J. Costa R, et al. Among authors: lister j. Cancer. 2011 Jun 15;117(12):2690-6. doi: 10.1002/cncr.25759. Epub 2010 Dec 23. Cancer. 2011. PMID: 21656746 Free article.

3

Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia.

Sadashiv SK, Hilton C, Khan C, Rossetti JM, Benjamin HL, Fazal S, Sahovic E, Shadduck RK, Lister J. Sadashiv SK, et al. Among authors: lister j. Cancer Med. 2014 Dec;3(6):1570-8. doi: 10.1002/cam4.321. Epub 2014 Aug 16. Cancer Med. 2014. PMID: 25132519 Free PMC article. Clinical Trial.

4

Treatment of myelodysplastic syndromes with 5-azacytidine.

Gryn J, Zeigler ZR, Shadduck RK, Lister J, Raymond JM, Sbeitan I, Srodes C, Meisner D, Evans C. Gryn J, et al. Among authors: lister j. Leuk Res. 2002 Oct;26(10):893-7. doi: 10.1016/s0145-2126(02)00028-0. Leuk Res. 2002. PMID: 12163049

5

Factors affecting purification of CD34(+) peripheral blood stem cells using the Baxter Isolex 300i.

Gryn J, Shadduck RK, Lister J, Zeigler ZR, Raymond JM. Gryn J, et al. Among authors: lister j. J Hematother Stem Cell Res. 2002 Aug;11(4):719-30. doi: 10.1089/15258160260194875. J Hematother Stem Cell Res. 2002. PMID: 12201961

6

Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation.

Bartynski WS, Zeigler ZR, Shadduck RK, Lister J. Bartynski WS, et al. Among authors: lister j. AJNR Am J Neuroradiol. 2004 Feb;25(2):261-9. AJNR Am J Neuroradiol. 2004. PMID: 14970028 Free PMC article.

7

Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.

Bartynski WS, Zeigler ZR, Shadduck RK, Lister J. Bartynski WS, et al. Among authors: lister j. Neurocrit Care. 2005;3(1):33-45. doi: 10.1385/NCC:3:1:033. Neurocrit Care. 2005. PMID: 16159093

8

Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.

Lister J, Gryn JF, McQueen KL, Harris DT, Rossetti JM, Shadduck RK. Lister J, et al. Stem Cells Dev. 2007 Feb;16(1):177-86. doi: 10.1089/scd.2006.06500-HB. Stem Cells Dev. 2007. PMID: 17348813 Clinical Trial.

9

Azacitidine in the management of patients with myelodysplastic syndromes.

Khan C, Pathe N, Fazal S, Lister J, Rossetti JM. Khan C, et al. Among authors: lister j. Ther Adv Hematol. 2012 Dec;3(6):355-73. doi: 10.1177/2040620712464882. Ther Adv Hematol. 2012. PMID: 23606938 Free PMC article.

10

Localized lymphoid relapse in the pancreas following allogeneic hematopoietic stem cell transplant for chronic myelogenous leukemia.

Rossetti JM, Lister J, Shadduck RK, Bloom E, Geyer SJ, Caushaj PF, Homann J, Papasavas P, Cedar M. Rossetti JM, et al. Among authors: lister j. Leuk Lymphoma. 2003 Jun;44(6):1071-4. doi: 10.1080/1042819031000068089. Leuk Lymphoma. 2003. PMID: 12854913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

764 results

Search Page